TargetMol

Mianserin hydrochloride

Product Code:
 
TAR-T0783
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0783-25mg25mg£96.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0783-50mg50mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0783-100mg100mg£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0783-200mg200mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0783-500mg500mg£215.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Mianserin hydrochloride is a tetracyclic compound with antidepressant effects. it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. It may cause drowsiness and hematological problems.
CAS:
21535-47-7
Formula:
C18H21ClN2
Molecular Weight:
300.83
Pathway:
Endocrinology/Hormones; GPCR/G Protein; Immunology/Inflammation; Neuroscience
Purity:
0.9955
SMILES:
Cl.CN1CCN2C(C1)c1ccccc1Cc1ccccc21
Target:
Dopamine Receptor; 5-HT Receptor; Opioid Receptor; Adrenergic Receptor; Histamine Receptor

References

1. de Boer TH, et al. J Pharmacol Exp Ther,1996, 277(2), 852-860. 2. Rocha B, et al. Eur J Pharmacol,1994, 262(1-2), 125-131. 3. Nakamura S, et al. Neuroreport, 1991, 2(9), 525-528. 4. Plech A, et al. Psychopharmacology (Berl),1995, 119(4), 466-473. 5. Tanda G, et al. Psychopharmacology (Berl),1996, 123(2), 127-130.